The question is, what do they gain by purchasing the debts? if not, can they resume the same production without the patents and IPs of BioAmber? also did BioAmber really sold off everything, including the patents and IPs for only $ 4.3 Mil? One last question, currently the CURSIP is suspended, is there a time frame where it changes to RESUMED, CANCELLED or DELETED?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.